Pharvaris N.V.
PHVS · NASDAQ
Bulios Fair Price
$29.96
16.8% downside
Trenutna cena
$36.02
Po podatkih Bulios Fair Price je delnica PHVS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Pharvaris N.V. (PHVS) is a biotechnology company focused on developing innovative drugs for the treatment of rare diseases, particularly angioedema disorders. The company utilizes advanced technologies and modern approaches to discover new drug candidates that can improve the quality of life for patients suffering from these conditions. Pharvaris N.V. is focused on developing drugs targeting specific molecular mechanisms that can provide effective treatment with minimal side effects. Shares of Pharvaris N.V. (PHVS) could be an intriguing investment opportunity for investors monitoring the biotechnology sector and seeking companies with the potential to change the therapeutic paradigm for a range of diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Berndt Modig
Employees
148
Headquarters
Zug
Prihajajoči dogodki
Earnings
Upcoming earnings report